Opportunity
Federal Register #337-TA-1446
ITC Investigation Termination and Controlled Substance Registration Notices
Buyer
International Trade Commission
Posted
May 04, 2026
Identifier
337-TA-1446
NAICS
926150
This summary covers the U.S. International Trade Commission's notice of termination for Investigation No. 337-TA-1446 and related controlled substance registration applications:
Government Buyer
- U.S. International Trade Commission (ITC)
OEMs and Vendors Mentioned
- Molex, LLC
- TE Connectivity Corporation (TECC)
- Amphenol Corporation
- Credo Semiconductor Inc.
- ANI Pharmaceuticals Inc.
- Patheon API Inc.
Products/Services Requested
- No procurement or purchase is being requested in the ITC notice; the document is a termination of an investigation into active electrical cables and components (no part numbers or quantities specified)
- Controlled substances for research and distribution (from related registration applications):
- Levorphanol (Part Number: 9220)
- Tapentadol (Part Number: 9780)
- Dimethyltryptamine (Part Number: 7435)
- Psilocybin (Part Number: 7437)
- Psilocyn (Part Number: 7438)
Unique or Notable Requirements
- The ITC investigation was terminated based on settlement agreements with Molex, LLC and TE Connectivity Corporation
- Controlled substances are to be imported or manufactured for research, clinical trials, and distribution to customers (not for procurement)
Locations
- U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436 (federal office)
- Other referenced locations include Lisle, IL; Berwyn, PA; San Jose, CA; Wallingford, CT; Galway, Ireland; East Windsor, NJ; Florence, SC (associated with parties in the investigation or registration applications)
Description
The U.S. International Trade Commission has issued a notice regarding the termination of an investigation into certain active electrical cables and components. The investigation involved respondents Molex, LLC and TE Connectivity Corporation and was based on allegations of patent infringement. The Commission determined not to review two initial determinations that terminate the investigation as to these respondents based on settlement agreements. Consequently, the investigation is terminated in its entirety.